chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient contracted Covid19 after being fully vaccinated; Patient contracted Covid19 after being fully vaccinated; This is a spontaneous report from a contactable nurse. A 56-year-old male consumer (patient) received bnt162b2 (lot/batch number unknown) via an unspecified route of administration on 28Jan2021 at 1st dose single, and then via an unspecified route of administration on 24Feb2021 at 2nd dose single, all for COVID-19 immunization. The patient had no known allergies. Medical history included hypertension from an unknown date. There was none other medications the patient received within 2 weeks of vaccination. The patient contracted Covid19 after being fully vaccinated on 25May2021. Adverse event resulted in: Doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures, which included Covid test name post vaccination: Rapid PCR test, covid test type post vaccination: Nasal Swab, results: positive on 25May2021. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. It was unknown if the patient receive any other vaccines within 4 weeks prior to the COVID vaccine. Therapeutic measures were taken as a result of event which included symptom management. The outcome of event was recovering.  Information about lot/batch number has been requested.; Sender's Comments: Based on the known safety profile and a positive temporal association, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported Covid-19 as a result of possible Vaccination Failure.
Pt. fainted and rolled off of exam table onto tile floor - went to ER for evaluation - diag. of syncope and concussion.
After injection was complete, she sat there for a minute. Soon she felt faint, then passed out. After passing out, her hands/arms started tensing up, back started arching, and she was shaking out of the chair. Looked like a seizure.
Pt was reported to have a seizure-like event: unresponsive, eyes rolling back in her head, arms and upper body shaking.  She was lowered to the ground by a co-worker and then was observed to loose consciousness.  Emergency services was called.  Vitals were all within normal limits, blood glucose was normal also.  Pt refused to go to the hospital at that time.  She later went to urgent care, they were unable to collect blood sample but EKG was normal.  She was encouraged to go to the hospital.  She refused and was later convinced by her co-worker to go to her PCP for follow up evaluation.
pt cried 3 hrs straight p/vax given; mom made phone call to own MD who stated no concerns; mom gave APAP;
After I got the vaccine, my period has been starting 5 to 7 days early every month.
Right after my vaccination I got a dry cough, fatigue, and felt feverish. When it got to Friday, I tested myself for COVID-19 and it was negative. I went in to get tested at 4pm and it was positive for COVID-19. They prescribed me an antiviral. I developed TGA on 11/20/2022 for 2 hours. They took me to the doctor, and they did an MRI and echocardiogram. Everything was normal
Presented to emergency department on 5/15/21 with weakness, lethargy, and increased confusion with onset approximately 4 to 5 days ago.  She had a positive COVID exposure prior to presentation. Patient was admitted for further management of COVID-19 infection and acute kidney injury.  Patient is admitted at time of writing.
This is a spontaneous report from a contactable consumer repotting for her daughter. A 18-year-old female patient received the first dose of TRUMENBA, intramuscular in right arm, on 29FEB2015 a 16:00, at single dose. The patient medical history was not reported. The patient's concomitant medications were not reported. On 25FEB2016, about 4 hours after vaccination, the patient experienced pain at injection site to her right shoulder and chills all over. As a result of the events the patient took ibuprofen. Events outcome was unknown. Follow-up (06APR2016): Follow up attempts are completed. No  further information is expected.
p/vax that noc inj site became sore & swollen next day felt like hit by a car-really sick to stomach, h/a, nausea missed 2 days of work then relapse dizzy- h/a, still feeling achy w/h/a-allerg rxn;stomach cramping;
Dose 1: Administration Date: 01-Nov-2021 and Dose 2: Administration Date: 21-Nov-2021; This spontaneous case was reported by a physician and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1: Administration Date: 01-Nov-2021 and Dose 2: Administration Date: 21-Nov-2021) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1: Administration Date: 01-Nov-2021 and Dose 2: Administration Date: 21-Nov-2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1: Administration Date: 01-Nov-2021 and Dose 2: Administration Date: 21-Nov-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.   This case was linked to MOD-2022-537607 (Patient Link).
patient received a dose of improperly stored Proquad; no additional adverse effect; This spontaneous case was received from an immunization consultant regarding to a patient of unknown age, gender and ethnicity. The patient's concurrent conditions, medical history, drug allergies and concomitant therapies were not reported.   On 27-JAN-2020, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # S009756 with expiration date on 27-SEP-2020) administered subcutaneously for prophylaxis (strength and dose were not reported). The vaccine was reconstituted with a properly stored sterile diluent. The vaccine was exposed to a temperature between 6 °F and 14 °F (with an average temperature of 11.3 °F) for 12 hours and 30 minutes. No previous temperature excursion was reported. No adverse effect was reported. The report was received due to a data logger.   Albumin status has been verified for measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # S009756) to be recombinant human albumin.  This is one of several reports received from the same source.; Sender's Comments:  US-009507513-2005USA004496: US-009507513-2005USA004621: US-009507513-2005USA004591:
Headache, body aches, chills,nausea.  injection site rash over the first 24 hours  Headache, nausea, and site rash continued for full 48-60 hours. Headache was the most painful side effect. No medicine (Advil, Tylenol) would relieve it
Asthma attack with wheezing, coughing, shortness of breath. Used an albuterol inhaler.  Still currently having symptoms.
patient reports "chest pain after 5 minutes of receiving the vaccine"; then in the past 6 days, body aches and intractable headache
So what happened was, on Sunday Sept 5th my youngest daughter woke up with a fever of 103 F and a runny nose. The fever persisted all day even with Tylenol so I located a rapid test and did it for her, so she went to the hospital and it was positive, this is all a back story and probably how I ended up getting Covid. On Thursday Sept 2 I had to go to the OB on call at the hospital because I was having a lot of Bronchitis symptoms. They treated me with antibiotics, so I went on that. While still on the antibiotics, on the 8th of September I woke up with congestion, body aches, no fever, muscles and bones hurting and I had a cough I think, a mild one. I had a lot of post nasal drip drainage going on at that time. Then, the symptoms persisted and then when I woke up on Sept. 10th 2021 and I could not smell or taste anymore. Then over the weekend I was still not feeling well and having trouble breathing so I took my albuterol inhaler. On Monday, the 13th I got the antibody treatment. On Sept 14th I felt a little better and by Friday the 17th I felt a bit better. I was finally cleared for end of isolation on Sept. 19th 2021, I was definitely better but no taste and smell still and a lot of drainage. Maybe by the 24th of Sept I was feeling a lot better but still no taste and smell, the smell came back on Oct 1st, but very minimal and fluctuated. By now, 10/18/2021 it is better but the lack of taste and smell is still there, it is subdued and goes in and out throughout the day. So for my pregnancies, I have had some miscarriages but I have never had any of these symptoms. I have three daughters with no complications in their births. Right now I am 29 weeks, my date of delivery will be 1/02/2022.
Discharge Provider:   Primary Care Provider: MD Admission Date: 3/27/2023 Discharge Date: Mar 30, 2023  PRESENTING PROBLEM: Shortness of breath [R06.02] Acute right-sided heart failure [I50.811] Pleural effusion [J90] Atrial fibrillation with rapid ventricular response [I48.91] COVID-19 [U07.1]   HOSPITAL COURSE: The patient is a 94 y.o. female who presented today to the ER secondary to shortness of breath.  Six days ago, she started to complain of gradual progressive shortness of breath together with a dry cough and congestion.  She is physically active, walks an hour daily.   Patient was started on IV diuretics.  Cardiology was consulted.  An echo was done.  New systolic congestive heart failure was noted with an EF of 46%.  Patient was able to have her diuretics deescalate to oral and she tolerated them well. Patient was also to noted to have new onset atrial fibrillation.  Patient started on IV heparin drip and oral metoprolol.  She was well rate controlled.  She was eventually able to be transition to oral anticoagulation at discharge.  Cardiology felt there was no need for urgent cardioversion and had plans to follow-up with the patient in the office. Patient was also noted to have pleural effusion.  IR was consulted and a thoracentesis was performed.  With the diuresis and the thoracentesis, patient felt her breathing was back to baseline and she felt safe for discharge.  Patient is medically stable for discharge.
Sore arm, headache, dizzy, tired, chill.  a little fever, from 6 hrs to 40 hrs after dose.
Swelling of the lymph node in left armpit that has also spread upwards into my chest area. On 2/19/21 it started to get red and by 2/20/21 it has gotten bigger and darker and looks like bruising
dose administered after beyond use time. Dose given 6 hours and 37 minutes after vial first dose was drawn which exceeds Pfizer recommended time of 6 hours.
first shot in December 2019 but I never took second; This case was reported by a consumer and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in December 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The reporter was patient. The age at vaccination was not applicable for this report. The patient had the first Shingrix shot but he/she never took the second shot, which led to incomplete course of vaccination.  The patient asked should get the second one now almost two years later or do he/she need to start over with the first shot?
Patient presented to the pharmacy today (9/26/2023) to state he had tinnitus start roughly one month after his last dose of Moderna in August of 2021.  Patient still suffers from the tinnitus to this day.
Red, warm, swollen, painful circular area that has grown in size in the past 12 hours
Pfizer-BioNTech COVID-19 Vaccine EUA. Patient received 3rd dose of Pfizer COVID-19 vaccine on 8/25/2021 without incident. Reports yesterday (9/20/2021) at approximately 2:00pm he began feeling a burning sensation on the back of his neck and on the right side of his upper body. States red rash was present. States the rash is intermittent but area remains sensitive. States he started taking Benadryl once rash developed.  Examined today by Dr. and diagnosed with herpes zoster.
About 6-7, days after the vaccine I started getting a rash on my elbow, have a stiff neck, and feel tired. Tody I have body aches and the injection site has a lump and is tender.
Patient called on 10/24/18 and said that the night of the flu shot (10/21/18) she started getting a fever, her back was hurting, her body was aching pretty bad, had a headache, flu like symptoms, she said she did not have any nausea, vomiting, no swelling, or diarrhea.
Patient was admitted to Hospital on 11/23/2021 for COVID related symptoms. This is considered a breakthrough case.
Extreme joint pain, knee & hip, affecting ability to function in normal activities of daily living, mobility, etc.  And also requiring opioid  pain medication daily in order to treat/manage debilitating joint pain.
1 of 4 adults vaxed 9NOV94 & exp a fever of 103;persisting @ least 3 days & flu-like sxs;unk if treatment was prescribed;recovered;pt recvd a flu shot w/in 4wks of pnu-immune immun
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported. On 22-NOV-2016 the patient was vaccinated with expired dose of PNEUMVOAX 23 (dosing details were not reported) (lot # L012042, expiry date: 18-NOV-2016) intramuscularly. The dose had not been exposed to any temperatures outside of the recommended range. The patient had not experienced any adverse effects. Additional information has been requested.
Patient has vomited 3 times over the course of 24 hours (once during the day and twice in the middle of the night between 10/24/06 - 10/25/06), has had diarrhea, and has been complaining of stomach pains.  Patient has also developed a rash on her lower stomach and left leg that looks like red pindots.
Runny nose, congestion started on 8/14.  Test + 8/17.  Is part  has not done her 2nd/6 month lab draw.  Instructed to quarantine and await further guidance from DOH.  Instructed get her Quasar labs drawn after released from quarantine by DOH.  Last day worked 8/14, called in sick 8/17/2021. Covid positive after vaccination
Rash/ hives, uncontrollable itching of palms neck and wrists. Lasted for a week and required steroids to stop
His left arm where Pneumovax 23 shot was given felt like it was on fire; It was hot to touch, it was red and was hurting; It was hot to touch, it was red and was hurting; It was hot to touch, it was red and was hurting; This spontaneous report has been received from a 70-year-old male patient, reporting on himself. The patient's concurrent conditions, and concomitant therapies were not reported. His medical history included "some reactions" to paracetamol (TYLENOL) with codeine 4, and aspirin with codeine 4.  He said he never had any reactions to any other medications.   On 05-AUG-2017, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (lot #, expiration date, strength, dose, and route of administration were not provided) in his left arm for prevention of pneumococcal.  On 07-AUG-2017, his left arm where pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) shot was given felt like it was on fire (Burning sensation), It was hot to touch, it was red, and was hurting (Vaccination site warmth/erythema/pain). He saw his health care professional (HCP) on the same date, and they give him  diphenhydramine (BENADRYL), orally, and some other "shot" (name unknown) that helped him the side effects he was experiencing. No additional adverse events (AE) were reported. It was unknown wether laboratories were performed.   At the reporting time, the outcome for the adverse events was unknown.    The causal relationship between the patient's burning sensation in his left arm, vaccination site warmth, erythema, pain and vaccination with polyvalent (23-valent) (PNEUMOVAX23) was not reported.
Stated that he was severely intoxicated; Could not breath; Dizzy; Severe allergic reaction; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 03May2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: POISONING (medically significant), outcome "unknown", described as "Stated that he was severely intoxicated"; DYSPNOEA (non-serious), outcome "unknown", described as "Could not breath"; DIZZINESS (non-serious), outcome "unknown", described as "Dizzy"; HYPERSENSITIVITY (non-serious), outcome "unknown", described as "Severe allergic reaction".  Additional Context: Caller stated that he was wondering, had a spat with the doctor's office and wanted to know what would be the treatment for severe allergic reaction. Stated that he had one in the office. Stated that she had the vaccine and had a visit and got the shot while he was in there. Stated that he was severely intoxicated, could not breathe and dizzy. Wanted to know if they should have put him on oxygen or anything. Wanted to know why they left him sitting in the hall for 30 minutes after saying they could perfectly handle any situation. Wanted to know the immediate response for someone having a severe allergic reaction. Is for the Pfizer Covid 19. Stated that this is his first dose. Stated that once he reported it that someone came out and basically held his hand and did not do anything. Stated that it has been almost a year and that he cannot get any answers from them and wanted to get some facts from Pfizer. Caller rambling on; unable to clarify details. Stated that he had the shot on 03May2021.  The lot number for bnt162b2 was not provided and will be requested during follow up.
I had a stroke, dissection of right neck artery. ER visit turned into hospital admissions to run cognitive function testing every two hours for about 24 hours. I had CT with and without dye, MRI with and without dye, cholesterol testing, glucose testing, neurological appts and neurological physical therapy.
Patient had second Shingrix vaccine  on 3/10/2023. On 3/20/2023 She had neck and back pain that night she put a heat pack on it. The following day on 3/21/2023 she woke up with a blister 2cmx1cm on right deltoid. When the blister started it was only circular on the outside with no blister on the inside. Later that day the inside started to blister.
A nurse reported that an adult female pt did not respond to the hepatitis B vaccine recombinant (Engerix-B) immunization series.  The pt's medical history, concurrent conditions, and concurrent medications were not reported. The pt received a series of injections of hepatitis B vaccine (manufacturer unknown) on unspecified dates.  It was subsequently determined that the pt "failed to respond" to the vaccine.  On unspecified dates, the pt received three injections of Engerix-B.  It was subsequently determined that the pt "failed to respond" to Engerix-B.
Redness and swelling to left arm. Give Benadryl and Motrin PRN. RTC if s/s worsen.
pt allegedly fainted p/leaving the clinic but still in the state building;found sitting on hallway floor upset & c/o contusion to rt lateral forehead;alerted & oriented x3;mom advised of head injury;soreness @ inj site;
Pfizer covid 19 vaccine lot # FJ6369 administered beyond use date of 03/25/2022, administered on 04/05/2022
Hot to touch; Red rash at the injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of INJECTION SITE ERYTHEMA (Red rash at the injection site) and INJECTION SITE WARMTH (Hot to touch) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Red rash at the injection site). On 25-Jan-2021, the patient experienced INJECTION SITE WARMTH (Hot to touch). At the time of the report, INJECTION SITE ERYTHEMA (Red rash at the injection site) and INJECTION SITE WARMTH (Hot to touch) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication includes Tylenol, and cold compress. No concomitant medications were provided by reporter.   Reporter did not allow further contact
pt recv vax 5JUN97 seemed OK p/vax;pt sat & then was lying flat on floor-had gen sz for 30-45sec;then awake & crying;examined by MD;
joint pain; fever; Arm was sore for the first 24 hours; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Arm was sore for the first 24 hours), ARTHRALGIA (joint pain) and PYREXIA (fever) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02AMZ0A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 virus test positive (Nurse and whole family were positive for COVID in November.). Concurrent medical conditions included Sjogren's syndrome.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore for the first 24 hours). On 12-Feb-2021, the patient experienced ARTHRALGIA (joint pain) and PYREXIA (fever). On 10-Feb-2021, PAIN IN EXTREMITY (Arm was sore for the first 24 hours) had resolved. At the time of the report, ARTHRALGIA (joint pain) and PYREXIA (fever) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided by reporter.